Valeant board member

In a new blog post, Bronte Capital analyst John Hempton explores some inconsistencies in Valeant Pharmaceuticals Intl Inc (NYSE: VRX)’s facts regarding board member Norma Provencio’s involvement in Heartronics/Signalife prior to her tenure at Valeant. After Provencio left Heartronics/...